Better Health, Naturally!

January 2011

In This Issue
Step 4: Don't Smoke
Dr. Noe's 10 Steps to Optimal Health
High Dose Vitamin D Called Into Question
Low Testosterone Common, Yet Treatable
The Research Says...

Quick Links

Subscribe to this Newsletter!

 

Step 4: Don't Smoke

 

Editor's Note: This is the third of a ten part series on Dr. Noe's "10 Steps to Optimal Health." See below for a recap of all 10 steps.

 

Most people are well aware of the risks of smoking - lung cancer, emphysema, asthma, heart attack, stroke, high blood pressure, blood clots, gum disease, acid reflux, and many other diseases. Most people are not aware that the risk of these diseases starts dropping fairly quickly after quitting. For example:

 

20 minutes

Blood pressure drops

8 hours

Carbon monoxide level in blood returns to normal

24 hours

Heart attack risk begins to decrease

2 weeks to 3 months

Circulation improves. Lung function increases up to 30%

1 to 9 months

Coughing and sinus congestion improve

1 year

Heart attack risk is cut in half

5 years

Stroke risk is reduced to that of a nonsmoker

10 years

Lung cancer risk is ½ of smokers. Risk of mouth, throat, esophagus, bladder, kidney, and pancreatic cancer decreases

15 years

Risk of heart attack is the same as a nonsmoker

 

While many people try to quit "cold turkey," nicotine is a powerfully addictive substance that can be very difficult to quit in this way. Two techniques that have been shown to improve the odds of success are nicotine replacement therapy and cessation counseling.

 

Nicotine replacement therapy (NRT) doubles your chances of success. It is provided as a patch, inhaler, nasal spray, or gum. NRT helps because it separates the physical addiction from the smoking habit so that they can be dealt with separately instead of all at once. Once you break the habit of smoking, you then slowly wean off the nicotine to address the physical addiction. NRT can reduce or eliminate the withdrawal symptoms that many people have when they quit smoking. NRT is free to all Vermonters, with or without insurance, when used in conjunction with smoking cessation counseling (see below).

 

Bupropion is a drug that reduces the nicotine craving and withdrawal symptoms. It does not contain any nicotine. Generally it is taken starting 2 weeks before you quit smoking and continuing for at least 7-12 weeks after you stop. There is evidence that combining this drug with NRT can be effective in helping people to stop smoking.

 

Smoking cessation counseling is offered free to all Vermonters. Group counseling is offered through every hospital in the state. To access this service, call your local hospital. Free, 24 hour, one-on-one quit coaching is also available via the QuitLine at 1-877-Yes-Quit (1-877-937-7848).

 

Online information, chat rooms, and support are also available to all Vermonters for free at www.quitnet.com.

 

Remember that it is never too late to try to quit smoking, even if you have attempted several times already. The average smoker makes 6 attempts at quitting before he or she quits for good. Each time you try you learn something new that makes you more likely to succeed the next time.

 

Source: Set Yourself Free, American Cancer Society

 

Dr. Noe's 10 Steps to Optimal Health
 

1.      Be physically active (at least 45-60 minutes, 6 days per week)

2.      Don't eat sugar or white flour (this includes maple syrup and honey)

3.      Eat a rainbow each day (at least 8-10 servings of fruits or vegetables in a variety of colors)

4.      Don't smoke

5.      Avoid your food allergens

6.      Consume omega 3 oils daily (fish, fish oil, flax oil)

7.      Take vitamin D daily (2000-4000 IU)

8.      Avoid excessive alcohol (7 drinks or less per week for women, 14 for men)

9.      Watch your stress

10.  Engage (with other people)

 

High Dose Vitamin D Called Into Question

 

The recent release of a new report on vitamin D and calcium by the Institute of Medicine has raised many questions about high doses of vitamin D. The authors, as reported in the New York Times and other publications, did not identify any benefit above 800 IU per day, and recommended a maximum dose of 4000 IU per day. I, on the other hand, have been routinely recommending doses of 4000-6000 IU per day for most people.

 

In recognition of the importance of vitamin D in bone health, the authors did raise the RDA of vitamin D up to 800 IU per day for adults over the age of 70 and 600 IU per day for everyone else 1 year of age or older. While their have now been a number of studies identifying possible benefits of higher doses of vitamin D, such as a possible reduction in the risk of heart disease, colon cancer, and breast cancer, the authors felt their was insufficient evidence to serve as a basis for the development of the RDA.

 

The authors did not find any evidence of toxicity below 10,000 IU per day of vitamin D. In the words of the authors, "What the data do suggest is that it would be unlikely to observe symptoms of toxicity at intakes below 10,000 IU..."  They did, however, find some evidence of possible harm from doses of vitamin D above 4000 IU per day. These risks included a possible increase in "all cause mortality" and several chronic diseases including pancreatic cancer.

 

It is important to note that the authors specifically stated that the data on higher doses of vitamin D (above 4000 IU per day) is sparse and is in no way conclusive either for benefit or for possible harm. It should also be noted that many of these risks follow what is known as a "J curve." In this case it is actually a backwards "J" where all cause mortality decreases as vitamin D dose increases at lower levels (the vertical part of the J), then flattens out with no further reduction in risk as vitamin D dose continues to increase (the bottom part of the J), and then actually starts going up again as the dose further increases. In the case of all cause mortality, the risk of death is much higher when vitamin D is deficient than when it is in excess. The actual possible increase in risk of all cause mortality is very small. In most cases the curve is actually more like an "L" rather than a "J," where the risk bottoms out and then stays low or shows a slight increase.

 

Another factor to consider in interpreting this report is that the authors did not differentiate between synthetic vitamin D2 and natural vitamin D3. While the authors felt that there was no difference between these forms of vitamin D, others disagree.

 

Lastly, it is important to note that the authors based their recommendations on normal, healthy people. Those with certain health conditions, such as, for example, osteoporosis, may have different requirements.

 

In the end, this report is in no way a definitive statement on high doses of vitamin D. It does, however, call into question the benefits and risks of doses of vitamin D above 4000 IU per day. To that end, I am at least temporarily reducing my recommended daily dose of vitamin D from 4000-6000 IU per day to 2000-4000 IU per day.

 

The full report can be found at www.iom.edu/vitamind (it is 999 pages long). A short review of the report was published in the Journal of Endocrinology and Metabolism on 11/29/10.

 

Low Testosterone Common, Yet Treatable

 

 

Throughout his adult life, a man depends on the hormone testosterone for production of sperm cells, the ability to gain and maintain an erection, and for his interest in sex.

 

But testosterone was important long before being called on to enhance a man's sex life. Testosterone plays a role in the formation of the male genitalia. Also, at the start of puberty, testosterone triggers and maintains the growth of facial and pubic hair, stimulates the deepening of a boy's voice, and develops muscle mass and strength, height, and genital size.

 

But the need for testosterone goes beyond a man's sexuality. Throughout a man's life, testosterone helps maintain bone mass, muscle mass, fat distribution, energy level, mood, and fertility. It helps build protein, and has an affect on how a man's body metabolizes carbohydrates and fats, and how his liver functions.

 

When Levels Are Low

 

Approximately one in 500 boys and men have some level of testosterone deficiency (also called hypogonadism). Low testosterone levels are not related to masculinity. "Macho" men are as just as likely to experience hypogonadism as any other man. Hypogonadism can be caused by many things, including:

 

·  Disease (such as mumps or HIV)

·  Trauma (a direct injury to the testes)

·  Genetic abnormalities (such as Klinefelter's syndrome or hemochromatosis)

·  Medication (such as prednisone or morphine)

·  Tumors

·  Medical treatment (such as radiation or chemotherapy)

·  Aging

 

The most common cause of testosterone deficiency is aging. On average, a man's testosterone levels start to drop 10 percent per decade beginning at age 30. When a man turns 50 years old, his production of testosterone decreases rapidly. By some estimates, as many as 68 percent of men older than age 70 have some level of testosterone deficiency.

 

The Consequences

 

To compensate for lower testosterone levels, a man's body produces higher amounts of sex hormone binding globulin (SHBG), further reducing the amount of testosterone available to muscles, blood production, brain, and more. Symptoms of lower testosterone in adult men include:

 

·  Bone loss

·  Decreased muscle mass

·  Decreased muscle strength

·  Decreased sex drive

·  Erectile dysfunction

·  Hot flashes

·  Increased breast size

·  Increased upper and central body fat

·  Infertility

·  Loss of body hair

·  Reduction in size of testicles

·  Irritability

·  Concentration difficulties

·  Depression

·  Memory loss

 

When testosterone levels are low enough, or low long enough, a man is at increased risk for osteoporosis. It's possible that as many as one in eight men age 50 and older has bone loss. Additionally, low testosterone levels have been linked with atherosclerosis, suggesting that hypogonadism puts a man at increased risk for cardiovascular problems. Finally, low testosterone levels has been linked with a decline in memory and other cognitive skills in older men.

 

The Solution

 

If a man's healthcare team determines he has hypogonadism, he probably would benefit from testosterone replacement therapy. Men taking testosterone supplements generally experience physical and psychological improvements.

 

Supplemental testosterone can be used as pills, injections, patches, and gel. Some men should not receive testosterone replacement therapy, such as those with prostate cancer. Ask your doctor which product, if any, would work best for you.

 

Sources: 1)Patient's guide to low testosterone. The Hormone Foundation and the Endocrine Society. 2) Fukui M, et al. Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. Diabetes Care; 26(6). 3) Free testosterone predicts memory, cognition in older men. National Institutes of Health. © Wellsource, Inc., used with permission

 

 

The Research Says...

 

Physical Fitness Cuts Frequencies of Colds, URTIs

 

A study has found that those who get aerobic exercise more often have a reduced frequency of upper respiratory tract infections (URTIs), such as colds. The effect also was seen in those who perceive themselves as physically fit; the severity of cold symptoms was 41 percent less for those who believed they were fit and 31 percent reduced for those who were, in fact, the most active. The total number of days with cold symptoms was about half for those who reported getting aerobic activity five days a week or more, compared to those with the most sedentary lifestyles. Researchers speculate that the effect works this way: bouts of aerobic exercise boost immune system cells but they fall back a few hours later; but each exercise round may increase surveillance by the immune system, of harmful viruses and bacteria. Regardless of exercise, honorable mention for getting fewer URTIs went to those who were male, older and married. This study was released November 1, 2010 and will be published in a future issue of the British Journal of Sports Medicine. It can be read online now at http://bit.ly/cJ4bSB but this requires a subscription or payment.

 

Black Raspberries Cut Colon Cancer Risk

 

A study has concluded that consumption of black raspberries is highly effective in reducing the risk of colorectal cancer. In a mouse study, researchers fed two groups a Western-style diet (high in fat and low in calcium and vitamin D). They then altered the diet of the test group so that 10 percent of its food intake was comprised of freeze-dried black raspberry powder, which continued for 12 weeks. In the test group, the raspberry supplement produced a broad range of protective effects in the intestine, colon and rectum, and inhibited tumor formation. The black raspberries inhibited tumor development by suppressing a protein, known as beta-catenin. Tumor incidence was reduced by 45 percent and the number of individual tumors was reduced by 60 percent. Because black raspberries also reduce inflammation, this food may also help prevent a variety of inflammatory diseases, including heart disease. This study was released November 2, 2010 by the journal, Cancer Prevention Research. Although it will not be published in the journal until a future issue, it is available online now at http://bit.ly/cPTaWC for subscribers or those who pay the fee.

 

Further Evidence of Resveratrol's Cancer Preventive Effect

 

A study has found further evidence that resveratrol contributes to cancer chemopreventive activity (helps prevent cancer). In previous research on rodents, this polyphenol found in plants, notably in red grape skins and wine, has been shown to reduce levels of insulin-like growth factor-1 (IGF-1), a hormone similar to insulin. Researchers studied 40 human volunteers to assess effects of repeated dosing with resveratrol on two hormones: IGF-1 and IGF-binding protein-3 (IGFBP-3). A reduction in these factors is associated with anticancer activity. Subjects ingested resveratrol for 29 days, in dosages of 0.5, 1.0, 2.5, or 5.0 grams. There was a decrease for all volunteers in circulating IGF-1 and IGFBP-3 hormones but the greatest decrease was noted for those on 2.5 grams a day. Also, resveratrol was found to be safe, except that the higher dosages (2.5 and 5.0 grams) caused mild to moderate gastrointestinal problems. The study team concluded high resveratrol dosing contributes to cancer preventive activity in humans. This study was released November 2, 2010 by the journal, Cancer Research but will not be published until a future issue. It can be read online now at http://bit.ly/dyDfqs with subscription or fee payment.

 

Vitamin D Sufficiency Cuts Leukemia (CLL) Mortality by Half

 

A deficiency of vitamin D has been linked previously to a higher risk of cancer generally but studies have never looked at the vitamin's relation to leukemia. Now, a study has concluded that patients with chronic lymphocytic leukemia (CLL) who had sufficient levels of vitamin D at the time of initial diagnosis, experienced slower progression of the disease and were about half a likely to die from it. Researchers also found that increasing vitamin D levels in CLL patients produced longer survival times; and decreasing vitamin D levels resulted in shorter intervals between diagnosis and cancer progression. CLL is normally a slower progressing cancer and typically, treatment for CLL patients, even they are diagnosed at an early stage, is not initiated until symptoms develop, leaving patients feeling there is nothing they can do. Further studies may prove that the patients can use this period to boost their levels of vitamin D and have levels monitored by their health practitioner. Vitamin D is available from sunlight, certain foods such as fatty fish and eggs, and from supplements. This study was released November 3, 2010 but will not be published until a future issue of the journal, Blood. It is available online at http://bit.ly/cqyfP6 with subscription or fee payment.

 

Smoking Increases Risk of Fatal Breast Cancer

 

A study has clarified a link between smoking and breast cancer that is independent of socioeconomic, clinical and lifestyle factors. Women who are current smokers, or who have a history of smoking, have a greater risk of breast cancer progression and a 39 percent higher rate of dying from breast cancer. Smoking has been linked strongly to lung cancer and several other cancers but the association with breast cancer has been unclear. Smokers, or previous smokers, who were diagnosed with breast cancer also showed double the risk of subsequently dying from non-breast-cancer-related causes compared to women with the disease who had never smoked. The nine year study enrolled 2,265 multi-ethnic women. The researchers presented their findings on November 8, 2010 at the ninth annual Frontiers in Cancer Research hosted by the American Association for Cancer Research, in Philadelphia. It has not yet been published in any of the association's seven journals and it is not available online.

 

Tai Chi Relieves Arthritis Pain

 

The largest study to date on the Arthritis Foundation's Tai Chi program has found that participants - including those with rheumatoid arthritis, osteoarthritis, and fibromyalgia - showed moderate improvement in pain, fatigue, stiffness and well-being. While some received no tai chi intervention, others took the eight-week, twice-weekly tai chi course. All were assessed after the eight weeks by physical measures, such as walking speed and balance testing, as well as by self-reported differences. Individuals were recruited from urban and rural areas and from a southeastern state, North Carolina, and a northeastern state, New Jersey. Participants were included even if they were unable to stand so long as they could perform tai chi movements. Results proved consistent across these different groups. This study was presented November 8, 2010 at the annual scientific meeting of the American College of Rheumatology in Atlanta. It has not yet been reported in a journal and is not available online.

 

Lower Folate Levels Linked to an Increased Risk of Depression

 

A study has found that boosting folate, or folic acid, intake should be considered as a means to ward off the onset of clinical depression. The study looked at depressive symptoms as measured by the Patient Health Questionnaire (PHQ) and at blood levels of folate, vitamin B12 and homocysteine for 2,524 adults aged 20 to 85 years. Overall, women showed a higher score than men on the PHQ, indicating a greater incidence of depression. Also, blood levels of vitamin B12 and homocysteine showed no apparent association with depression generally, although older adults did show a higher risk of depression if they had higher homocysteine levels. However, people in the lowest third of blood levels of folate, compared with those in the highest third of folate status, showed a 37 percent greater risk of having significant depression symptoms (having a higher PHQ score). The researchers concluded that mental health outcomes might be improved if health practitioners took into account the dietary and supplement folate, or folic acid, intake of patients. The study was published in the November/December 2010 issue of Psychosomatic Medicine, Journal of Biobehavioral Medicine. It is available online at http://bit.ly/9IrbXc with subscription or access fee.

 

Brain Chemical May Be Behind Mood Benefits of Yoga

 

Research has suggested that yoga has a greater effect on mood and anxiety levels than walking and other forms of exercise. But the mechanism for this effect has been unclear. However, a new 12-week study ties together, on the one hand, the yoga-induced increase in the thalamus, of the antidepressant, nerve-regulating, brain chemical known as GABA; and on other hand, and the effect of improved mood and lessened anxiety. GABA activity often is reduced in patients with mood or anxiety disorders and drugs commonly are prescribed to increase GABA levels and treat these conditions. Yoga postures appear to have the same therapeutic effect as GABA activity-boosting medications but without any negative side effects. This may provide an objective basis for yoga's effect but the study team wrote that "the possible role of GABA in mediating the beneficial effects of yoga on mood and anxiety warrants further study." This study was published in the November, 2010 issue of the Journal of Alternative and Complementary Medicine and is available online at http://bit.ly/aLU3WU without subscription or fee.

 

DHA Improves Age-Related Cognitive Decline

 

A new, six-month study has found that the omega-3 fatty acid called docosahexaenoic acid (DHA) improves learning and memory function in healthy, older adults with age-related cognitive decline (ARCD). Fish oils are rich in DHA, which is the most abundant omega-3 fat in the human brain and retina. In previous research, higher DHA intake has been associated with a reduced risk of Alzheimer's disease. This study - which was reported in the November 2010 issue of the journal, Alzheimer's & Dementia: The Journal of the Alzheimer's Association - underscores the importance of early intervention with DHA. Another study - reported in the November 3, 2010 issue of the Journal of the American Medical Association (JAMA) - found DHA did not improve cognitive function in those already diagnosed with mild to moderate Alzheimer's disease. But researchers behind the Alzheimer's & Dementia study concluded that the key benefit may be seen only when DHA is taken over time and before Alzheimer's has developed; and the lead author of the JAMA study suggested results may have been different if DHA had been administered before the disease had progressed. The Alzheimer's & Dementia study is available online now at http://bit.ly/9Y556k with subscription or fee payment.

 

Poor or Insufficient Sleep Increases Heart Risk

 

Researchers have found that insufficient or poor-quality sleep causes higher levels of inflammation in the body. Inflammation is a risk factor for heart disease and stroke. The study team recorded sleep quality, using the Pittsburgh Sleep Quality Index survey, as well as the number of hours of sleep. Subjects regularly getting fewer than six hours of sleep, as well as those regularly getting a poor quality of sleep, had higher levels of three inflammation markers: fibrinogen, IL-6 and C-reactive protein (CRP). People in the highest third of CRP levels have been shown to have roughly twice the risk of heart attack, compared to those with lower levels, according to the American Heart Association and the Centers for Disease Control and Prevention. Previous studies have shown that people getting between seven and eight hours of sleep live longer, while those getting more than eight, or less than seven, are more likely to have high blood pressure, obesity, or psychological stress. Inflammation may be the mechanism by which poor sleep quality increases heart disease and stroke risk. This study was presented in Chicago on November 14, 2010 at the Scientific Sessions of the American Heart Association. It has not yet been journal-published.

 

Dim Light at Night Linked to Depression

 

Researchers have found that exposure to even a dim light while sleeping is sufficient to cause physical changes in an area of the brain that is associated with clinical depression. This is the first study to find that light at night, by itself, leads to a lower density of dendritic spines in the hippocampus region of the brain. (Dendritic spines are hair-like growths on brain cells, which are used to send chemical messages from one cell to another.) One previous study found that bright light during sleep periods causes depressive symptoms and another found light at night is linked to weight gain. But the new study focused on the dim light of 5 lux, which is similar to a switched-on television in an otherwise darkened room. The researchers speculate that exposure to light during sleep suppresses secretion of melatonin, the hormone that lets the body know when it is nighttime. This study was presented November 17, 2010 in San Diego at the annual meeting of the Society for Neuroscience. It has not yet been published in a journal and is not yet available online.

 

Pomegranate Juice Fights Cardiovascular Disease, Infection

 

A new study has concluded that drinking pomegranate juice three times daily for one year reduces the incidence of infections, inflammation, and oxidative stress in chronic kidney disease dialysis patients. (Oxidative stress is an imbalance between the production of chemically-reactive molecules containing oxygen and the body's ability to detoxify them; oxidation is implicated in numerous diseases, including Alzheimer's, Parkinson's and heart failure.) This means that pomegranate juice wards off a number of common complications of kidney dialysis, including a higher mortality rate due to infections and cardiovascular disease. (Cardiovascular disease can result from inflammation.) These findings support other studies that found pomegranate juice has a potent antioxidant effect. Pomegranate juice consumption could produce similar benefits in people with healthy kidneys but further research would be required. The study team stressed the need to monitor potassium levels in any juice taken by kidney patients, especially those with dietary potassium restrictions. This study was presented in Denver on the evening of November 18, 2010 at the 43rd Annual Meeting and Scientific Exposition of the American Society of Nephrology. It has not yet been published and is not available online.

 

High-Produce Diet Can Improve Kidney Function

 

In kidney patients, the Western diet produces an acidic environment, which has numerous negative effects that worsen with age and kidney functional decline. A new study has concluded that adhering to a diet high in fruits and vegetables, which counteracts this acidity, improves kidney function in patients with moderately reduced kidney function due to high blood pressure. Thirty days on a high-produce diet resulted in lower levels, in the urine, of three common indicators of kidney injury, which are known as albumin, transforming growth factor, and N-acetyl-beta-D-glucosaminidase. Researchers suggested that further studies be conducted to determine whether a diet high in fruits and vegetables could be a relatively inexpensive and natural intervention to prevent the worsening of kidney function in patients with high-blood-pressure-associated kidney disease. This study was presented November 20, 2010 in Denver at Renal Week 2010, a conference of the American Society of Nephrology. It has not yet been published in a journal and is not yet available online.

 

Smoking Increases Arthritis Risk

 

Researchers have concluded that cigarette smoking doubles the risk of rheumatoid arthritis (RA), at least among African-Americans. Both current and previous smokers are at greater risk. Also, smokers who have a genetic risk factor for RA - because they have the genetic factor known as "HLA-DRB1 shared epitope" - are four times as likely to develop the autoimmune disease. (RA is a chronic inflammatory disease that affects the joint lining, called the synovial membrane, and causes pain, swelling and redness in the joints. Seventy percent of those diagnosed with RA are women.) Heavy smoking was found in 54 percent of RA patients. These findings are generally consistent with previous studies suggesting a link between smoking and rheumatoid arthritis. However, this study specifically shows the link also applies to African-Americans and to what extent. This study will be published in the December 2010 issue of the journal, Arthritis & Rheumatism. It will be available online in December at the journal website at http://bit.ly/ikiA85 with subscription or access fee payment.

 

Some Flavonoid Types Lower High Blood Pressure Risk

 

A large, 14-year study has found that regular intake of anthocyanins and some flavones, including apigenin, may help to prevent hypertension, or high blood pressure. (Anthocyanins are flavonoid pigments found in abundance in red or purplish fruits and vegetables, including purple cabbage, beets, blueberries, cherries, raspberries, strawberries and purple grapes. Flavones are yellow pigments mainly found in cereals and herbs. Apigenin is a citrus bioflavonoid, found in citrus fruits such as oranges and grapefruit.) The reduction in high blood risk varied from six percent to 12 percent depending on the specific anthocyanin or flavone. These compounds appeared to exert a protective effect, among individuals who habitually ingested them, against hypertension through their ability to dilate arteries. This study was released November 24, 2010 by the American Journal of Clinical Nutrition but will not be published until a future issue of the journal. It is available now online at http://bit.ly/eZrseJ with journal subscription or access fee payment.

 

Pollutant May Cause Multiple Sclerosis

 

A new study has found the first strong laboratory evidence that an environmental pollutant may play a key role in the development of multiple sclerosis (MS). This toxic compound, acrolein (pronounced a-KRO-le-in), is found in tobacco smoke, as well as in some other pollutants such as auto exhaust. It is also produced by the body following serious nerve damage. Acrolein is a neurotoxin (damages nerve tissue) and the researchers believe that acrolein is what degrades the myelin in MS patients. (In multiple sclerosis, the myelin insulation surrounding nerve cells is destroyed and the nerve fibers themselves are damaged.) Also, acrolein induces the production of free radicals, which further injure tissues. Previous studies have shown this compound damages liver cells. Further research will be conducted by the same team, which has identified several compounds that may be able to bind with acrolein and remove it from the body. The group is also working to improve detection methods that can measure acrolein levels in MS patients. This recently-released study will be published in a future issue of the journal, Neuroscience, but is available online now at http://bit.ly/eNCHq1 with subscription or fee payment.

 

High-Antioxidant Diet May Lower Risk of One Type of Stroke

 

A study has found that a diet with a high total antioxidant capacity (TAC) may reduce the risk of a cerebral infarction, a type of ischemic stroke in the brain. (Ischemic strokes involve a restriction of the blood supply.) Prior studies have suggested that inflammation and oxidative stress play a role in ischemic strokes; and a high-antioxidant diet has been linked to a reduction of stress and higher levels of circulating anti-oxidants, suggesting a high TAC diet may help prevent ischemic strokes. This study of 41,620 men and women found only a minor reduction in the risks of strokes generally, with a high TAC diet. However, looking only at ischemic strokes, the study found a 59 percent reduction in this risk among those on a high TAC diet. Examining specific antioxidants, vitamin C itself was linked to a 42 percent lower risk of ischemic stroke; but high doses of vitamin E were linked to a three times higher risk of hemorrhagic stroke, a different type of stroke altogether. (Hemorrhagic stroke occurs when a blood vessel bursts inside the brain.) The researchers concluded that a high-antioxidant diet significantly reduces the risk of ischemic stroke. Just released, this study will not be published until a future issue of the Journal of Nutrition but is now available online at http://bit.ly/fMQAqm with fee payment or subscription.

 

BPA and Anti-Bacterial Soaps May Disrupt Immune System

 

Building on previous animal studies on bisphenol A (BPA), a new study has concluded that this compound may cause negative alterations to the human immune system. (BPA is found in many plastics, plastic food storage containers, thermal paper used for receipts, dental sealant, and as a protective plastic lining in food cans.) Although 200 previous studies have linked BPA with negative health effects on animals, this is the first study to find a link between the compound and the human immune system. Researchers detected higher levels of cytomegalovirus (CMV) antibody levels in people who had highest levels of BPA in their urine, suggesting their "cell-mediated immune system may not be functioning properly." They also noted greater incidence of allergies and hay fever in those with higher urine levels of triclosan. (Triclosan is found in antibacterial soaps, toothpaste, pens and medical devices.) This follows a September 20, 2010 study in the same journal suggesting human exposure to BPA may be greater than formerly suspected and through various avenues. This study was posted online November 30, 2010 by the journal, Environmental Health Perspectives and is available at http://bit.ly/hBVSvT with no fee or subscription required.

 

©2010 ChooseNewsDaily, used with permission

Green Mountain Natural Health

174 Elm St.
Montpelier, Vermont 05602
802-229-2038

www.GreenMountainHealth.com